Ben‐Quan Shen
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Angiogenesis and VEGF in Cancer, Chronic Lymphocytic Leukemia Research, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates(2012)980 cited
- → Vascular Endothelial Growth Factor Governs Endothelial Nitric-oxide Synthase Expression via a KDR/Flk-1 Receptor and a Protein Kinase C Signaling Pathway(1999)288 cited
- → Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities(2020)263 cited
- → Homologous Up-regulation of KDR/Flk-1 Receptor Expression by Vascular Endothelial Growth Factor in Vitro(1998)212 cited
- → Potential Mechanisms for Thrombocytopenia Development with Trastuzumab Emtansine (T-DM1)(2014)203 cited
- → Impact of Drug Conjugation on Pharmacokinetics and Tissue Distribution of Anti-STEAP1 Antibody–Drug Conjugates in Rats(2011)202 cited
- → Mechanisms of Acquired Resistance to Trastuzumab Emtansine in Breast Cancer Cells(2018)178 cited
- → Catabolic Fate and Pharmacokinetic Characterization of Trastuzumab Emtansine (T-DM1): an Emphasis on Preclinical and Clinical Catabolism(2012)135 cited
- → Highly specific off-target binding identified and eliminated during the humanization of an antibody against FGF receptor 4(2011)110 cited
- → Site-Specific Trastuzumab Maytansinoid Antibody–Drug Conjugates with Improved Therapeutic Activity through Linker and Antibody Engineering(2014)106 cited